DRG Debuts Calprotectin Poster at MEDLAB Asia Pacific 2017!
DRG Booth with Visitors. From Left: Mr. Gideon Lim; Dr. Cyril E. Geacintov, CEO & Founder of DRG; Dr.Aw Tar Choon, MD at Changi General Hospital in Singapore; Mrs. Josephine Teo; Mrs. Elke Geacintov; Mr. Wilhelm Sanger.
We are pleased to announce that the DRG Group successfully exhibited at MEDLAB Asia Pacific 2017. The show took place in Singapore at The Suntec Expo and Convention Centre, from April 3 – 5, 2017, and DRG exhibited at Booth #Q11.
DRG Founder, President, & CEO Dr. Cyril E. Geacintov was at the DRG booth and met with several customers and distributors. DRG’s Singapore distributor BioMedix helped DRG maintain the booth, BioMedix owners Mr. Gideon Lim and Ms. Josephine Teo pictured above.
DRG also featured a poster presentation at Medlab Asia Pacific 2017 entitled “Validation of Fecal Calprotectin on the DRG:Hybrid-XL Analyzer.” You can find a link to the poster here. The study concluded that the DRG:Hybrid-XL analyzer is the first fully automated system for the quantification of Calprotectin in stool samples. The fecal calprotectin test shows diagnostic advantages over standard fecal occult blood screening in colorectal cancer and is a much better predictor of relapse.
DRG offered live demonstrations of our fully automated random access analyzer: DRG:HYBRiD-XL®. DRG is also proud to highlight our newest ELISAs like DHT-optimized and Hepcidin 25 (bioactive) High Sensitive ELISA kit.
To learn more about DRG’s Hepcidin kit or the DRG:HYBRiD-XL®, please visit our site here!
Latest posts by Gregory C. Guest (see all)
- DRG distributor “SERION-BRAZIL” successfully attends Brazilian Laboratory Medicine Exhibition in Sao Paulo, Brazil - November 22, 2017
- HYBRiD-XL Launch NEWS: DRG is expanding the test menu with TM-CA 72-4! - November 8, 2017
- DRG´s Newly Optimized Salivary Testosterone Kit used in New Study! - September 18, 2017
News and Updates
DRG distributor “SERION-BRAZIL” successfully attends Brazilian Laboratory Medicine Exhibition in Sao Paulo, Brazil
DRG is proud to announce the new partnership with Serion-Brazil and looks forward to a longstanding and successful business relationship! Mr. Gustavo Ruales, DRG International's Latin American Sales Manager, also attended the exhibition to support...read more
We are proud to announce the launch of a new assays for DRG:HYBRiD-XL®: TM-CA 72-4. Clinical Application: Tumor Marker (gastrointestinal cancer) Tumor Marker (ovarian cancer) CA 72‑4 is the marker of choice for the therapeutic monitoring and follow-up...read more
New Poster presented using DRG´s newly optimized Salivary Testosterone Kit Ellie Shuo Jin, Doctoral Candidate in Clinical Psychology of the University of Texas at Austin, presented her poster at the Meeting of International Society of Psychoneuroendocrinology...read more
DRG is proud to announce that our TM-CA 72-4 ELISA Kit (EIA-5071) has been used in a recent cancer study done by NYU Winthrop Hospital. The DRG TM-CA 72-4 ELISA Kit is for sale in the United States as an RUO product and is CE marked for global sales. Please see...read more
DRG International, Inc., the authorized distributor for CHROMagar, recently attended the 2017 ASM Microbe General Meeting of the American Society for Microbiology in New Orleans, LA from June 1, 2017 – June 4, 2017. Attendees (pictured above, l to r) were Mr. Alberto...read more
Dear Customers, Suppliers, and Friends, We regret to inform you that Dr. Cyril E. Geacintov passed away on Tuesday, May 23. His death was sudden and unexpected. In his usual driven style he was working in the office until a few days ago and challenging his team on how...read more
DRG International, inc. recently launched our brand new Ecommerce site for USA customers! Click here to shop over 180 ELISA, Salivary ELISA, and CHROMagar products now: https://store.drg-international.com/ The Ecommerce store has over 180 products that are FDA...read more
DRG’s CA 72-4 ELISA Kit (EIA-5071), which uses antibodies licensed from the NIH, has been used in a recent study conducted by Winthrop University. The study used the DRG CA 72-4 ELISA Kit (EIA-5071) to explore the expression of CA72-4 compared to current FDA-approved...read more
DRG is pleased to officially announce that we are going to Medlab Dubai from February 6th-February 9th, 2017 at the Dubai International Convention & Exhibition Centre, attended by over 10,000 delegates. The conference features 11 CME-accredited conference...read more
We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked them questions about what makes them the worldwide leader in diagnostics. These are the key takeaways the top executives at DRG want you to remember. Michael Martini (full...read more
DRG’s staff is diverse and the company maintains a global presence requiring its staff to speak multiple languages as well as travel the world visiting DRG’s many offices and events. We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting...read more
We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked them each about what DRG’s strengths are and how they add value to customers and business partners. Wilhelm Saenger (full profile) Our flexibility, flexibility and...read more